RecruitingEarly Phase 1NCT07425535

Optic Nerve Head Strain in Non-glaucoma Subjects

Sponsor

Johns Hopkins University

Enrollment

30 participants

Start Date

Jun 24, 2026

Study Type

INTERVENTIONAL

Conditions

Glaucoma

Summary

Persons who do not have glaucoma will have pictures taken of the optic nerve with a standard camera before and 2 weeks after starting to take a daily glaucoma eye drop to lower eye pressure. These data will be used to compare to the same procedure performed with glaucoma patients to study how glaucoma injures the eye.

Eligibility

Min Age: 30 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Latanoprost (0.005%) for people with glaucoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLatanoprost (0.005%)

Participants take the eye drop daily for less than one month

Locations(1)

Johns Hopkins Hospital

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07425535

Related Trials

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

NCT059244778 locations

Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment

NCT073417631 location